This report was recently updated on March 24 2023 with the latest and most recent
market numbers
Liquid Biopsy Market Size, Share, Analysis - Forecasts To 2025 - Global Market Estimates
The market report is designed to provide a complete view on the global liquid biopsy market. This business intelligence report has been categorised into qualitative and quantitative insights over the forecast period (2017-2025). The demand and supply matrix section falls under the qualitative information category, wherein, the market dynamics for liquid biopsy has been studied considering a short term forecast of the factors/variables influencing the industry. The market segments and their respective estimates & forecasts have been covered under the quantitative information category. Forecasts & trend analysis for each country and region is also available in the study. The report concludes by providing competitor analysis for major market participants profiled by analysing their organic & inorganic growth strategies, regional presence, and product portfolio among others.
Vendor Landscape: Liquid Biopsy Market
The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence of companies.
End-User Landscape (Consumer Profile): Liquid Biopsy Market
The report provides a detailed list of end-users operating across the world. The end-user landscape includes consumer contact details, geographical presence, revenue, product portfolio, organic and inorganic growth strategies among others.
Competitor Analysis:Liquid Biopsy Market
The major companies profiled in the liquid biopsy market include Illumina, Inc., QIAGEN N.V., Roche Diagnostics, Menarini Silicon Biosystems, Genomic Health, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Myriad Genetics, Inc., Biocept, Inc., Guardant Health, Inc., and MDxHealth SA.Companies are investing in innovation/R&D, brand building, and fostering strong relationships with customers to enhancetheir competitive position.
Please note: This is not an exhaustive list of companies profiled in the report.
We value your investment and offer free customization with every report to fulfil your exact research needs.
The global Liquid Biopsy Market has been studied from the year 2016 till 2025. However, the CAGR provided in the report is from the year 2017 to 2025. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Liquid Biopsy Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.
A dedicated client engagement team for round the clock support in terms of requirement gathering, query handling, and any other support activity.
More than 50% of innovation comes from the voice of the customer through which our analysts find blindspots in your revenue decisions.
The best vision is actionable insights across high growth markets with GMEs disruptive research methodology.
Disruptive research that correlates markets, technologies, new use cases and companies.
80% of Fortune 2000 use GME for their growth strategies.
Get in-depth analysis of the COVID-19 impact on this study
Benchmarking the rapid strategy shifts of the Top 100 companies in this market space
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS
